SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC
Clinical trial NCT00440271 · TERMINATED
Trial details
- NCT number
- NCT00440271
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-10-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.